Responses

Download PDFPDF
Neurological eponyms? Take your Pick
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    My Outdated Fondness for Neurological Eponyms
    • Sheldon Benjamin, Neuropsychiatrist UMass Chan Medical School, Worcester MA, USA

    I cannot recall having enjoyed reading a neurology paper quite as much as I enjoyed reading Jason Warren's eloquent exposition on the pros and cons of eponyms in neurology. I was moved to read many of the references cited including Stigler's 1980 paper on his "law of eponymy" that undermines the entire notion of eponymous diseases.

    But despite my rational understanding that Frontotemporal Dementia has traveled a great distance from Arnold Pick to 3R-tauopathies; and that Julius Hallervorden and Hugo Spatz, who used murdered victims of the Nazis in their experiments, deserved to have their names stripped from their eponymous disease renamed as Pantothenate Kinase Associated Neurodegeneration (PKAN), I still appreciate most neurological eponyms. I appreciate them for a reason that Warren did not list. Throughout my career it has been curiosity about the origin of neurological eponyms that has led me to learn from and be inspired by the work of the many brilliant neurologists, psychiatrists, neuropathologists and neuropsychologists whose names became associated with these syndromes or observations, regardless of whether they were truly the first to describe them. Often it is the stories of our predecessors through which we inspire our students. I will certainly call a 3R-tauopathy a 3R-tauopathy in teaching my students but I might also digress and tell a brief tale of Arnold Pick of Prague, noting that he did not actually describe the intracell...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    On first looking into Warren’s eponyms.

    It is such a pleasure to read Prof Warren’s paper, “Neurological Eponyms? Take Your Pick.” In a journal renowned for offering neurologists both scholarly entertainment and useful data, his contribution is an exemplar.

    Prof Warren’s eloquent account, which modestly acknowledges earlier forays into the debate “Eponyms good or bad?”, presents a pastiche, historiography and statistical overview of a neurological subset, and proposes a definition of the ideal eponym, which, I suggest, might henceforth be known as ‘The Warren criteria.’

    The table of more than 170 eponyms (I did not tally them myself) sets a precedent as the largest in our journal’s history. I shall send it to my amanuensis to assist with the typography of dictation – a process Prof Warren highlights as hazardous for their correct use.

    The content promises many rabbit holes to tempt ventures in idle moments. As a starter, I could not resist looking up Brueghel syndrome, and his painting of a yawning older man, eyes closed. Unsure of the distinction from Meige’s syndrome, which also fails the Warren criteria as unhelpful, the literature soon reveals splitters advocating both eponyms be preserved.

    What of Williams Hurst’s acute haemorrhagic encephalomyelitis and a second New Zealander for this roll of honour, William Alexander - whose leukodystrophy with Rosenthal fibres (yet another eponym) bears his name? No doubt others will lament missing individuals, as the author warns.

    U...

    Show More
    Conflict of Interest:
    None declared.